IL6 and breast cancer: The supernatants from HSPB1 overexpressing cells led to increased migration ability of breast cancer cells and tube formation of HUVECs, while the supplement of IL6 neutralizing antibodies could partly attenuate the promoted effect (Fig. 7B).